The ESMO-Magnitude of Clinical Benefit Scale for novel oncology drugs: correspondence with three years of reimbursement decisions in Israel
Hammerman, Ariel, Greenberg-Dotan, Sari, Feldhamer, Ilan, Birnbaum, Yair, Cherny, Nathan I.Language:
english
Journal:
Expert Review of Pharmacoeconomics & Outcomes Research
DOI:
10.1080/14737167.2017.1343146
Date:
June, 2017
File:
PDF, 650 KB
english, 2017